Video Shorts

Highlighting Potential Future Updates to the HER2+ Breast Cancer Treatment Paradigm

Where Iberdomide Plus Daratumumab and Dexamethasone Fits in the R/R Myeloma Paradigm

Exploring Atebimetinib in Metastatic Pancreatic Cancer

Managing Sacituzumab Govitecan–Related AEs in Breast Cancer

Dry Eye vs ADC-Related AEs in Breast Cancer

PFS Data With TUB-040 in Platinum-Resistant Ovarian Cancer

One Second-line Therapy Trial Still Needed in HCC

The Implications of Biomarker Analyses With Sacituzumab Govitecan in TNBC

Exploring Real-World Dose Reductions of RET Inhibitors in RET+ NSCLC

Updated Efficacy Findings With Abemaciclib and Hormonal Therapy in Gynecologic Cancers

Navigating Molecular Testing in Multiple Myeloma

Exploring the Potential Role of CD24 in Lung Cancer

The Role of Optometry Referrals in the Breast Cancer ADC Treatment Plan

Public Libraries as a Resource for Cancer Information

Balazs Halmos, MD, Answers Josh Sabari, MD

The Mechanism of Action of Evorpacept in Breast Cancer

What Does the Future Hold for Cancer Vaccines in Pancreatic Cancer?

Unpacking Subgroup Data With First-Line Ipatasertib Plus Pembrolizumab in HNSCC

Outlining Questions About the Future of HR+ Breast Cancer Care

Defining the Importance of Real-World Data in Lung Cancer

The Rationale to Wait for Radiographic Progression Before Switching Breast Cancer Therapy

Examining the Cardiovascular Risks of Hormone Therapy in Prostate Cancer

The Importance of Giving the Most Effective Therapy Upfront in TNBC

Explaining ctDNA Analysis Findings From SERENA-6 in Breast Cancer

Targeting FcRH5 in Multiple Myeloma

Why Early CAR T-Cell Therapy Is a Game-Changer in Myeloma

Exploring the Future of Radiopharmaceuticals in Prostate Cancer

Exploring Brenetafusp in Melanoma

Exploring the Next Steps for Belzutifan in RCC

Discussing the Safety of Silicone Breast Implants